Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

3articles mentioning drugs

6drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: bismuth ×

bismuth

This drug is selected. Its supporting articles are shown below.

Articles mentioning bismuth

3 articles · page 1 of 1

IDDF2026-ABS-0349 High-level clarithromycin resistance creates an iron-dependent metabolic vulnerability targetable by bismuth: a real-world study in chinese pediatric helicobacter pylori infection

gutjnl · abstract · 2026-06-26 · 4 matching annotations

91.8%

Clarithromycin Bismuth Bismuth-CLA CLA H. pylori Helicobacter pylori BQT IDDF2026-ABS-0349

…t reversed by iron supplementation (IDDF2026-ABS-0349 Figure 1. Clarithromycin resistance confers susceptibility to bismuth via altered iron h…

IDDF2026-ABS-0122 Tegoprazan and low- or high-dose amoxicillin dual therapy versus bismuth plus clarithromycin-based triple therapy for helicobacter pylori eradication (TREAT): a multicenter, open-label, non-inferiority, randomized controlled trial

gutjnl · abstract · 2026-06-26 · 1 matching annotations

88.0%

amoxicillin clarithromycin tegoprazan esomeprazole bismuth levofloxacin Helicobacter pylori H. pylori EBAC

…hree times daily + tegoprazan), or EBAC (esomeprazole, bismuth, amoxicillin, clarithromycin). Randomization was performed via a centralized…

IDDF2026-ABS-0350 Closing the additive window: suboptimal metronidazole dosing abolishes bismuth benefit in paediatric helicobacter pylori infection—a real-world study in china

gutjnl · abstract · 2026-06-26 · 1 matching annotations

80.9%

metronidazole bismuth clarithromycin H. pylori Helicobacter pylori National Children’s Medical Centre BQT

… resistance regions, but remain silent on dose optimisation for metronidazole (MET) resistance—now exceeding 50% in the Asia-Pacific. This st…